178 related articles for article (PubMed ID: 10862198)
1. Disruption of TGFbeta signaling pathways in human pancreatic cancer cells.
Simeone DM; Pham T; Logsdon CD
Ann Surg; 2000 Jul; 232(1):73-80. PubMed ID: 10862198
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.
Villanueva A; García C; Paules AB; Vicente M; Megías M; Reyes G; de Villalonga P; Agell N; Lluís F; Bachs O; Capellá G
Oncogene; 1998 Oct; 17(15):1969-78. PubMed ID: 9788440
[TBL] [Abstract][Full Text] [Related]
4. Identification of a gadd45beta 3' enhancer that mediates SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor beta.
Major MB; Jones DA
J Biol Chem; 2004 Feb; 279(7):5278-87. PubMed ID: 14630914
[TBL] [Abstract][Full Text] [Related]
5. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E; Letamendia A; Attisano L
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Lin X; Feng XH
World J Surg; 2005 Mar; 29(3):312-6. PubMed ID: 15706432
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells.
Dai JL; Schutte M; Bansal RK; Wilentz RE; Sugar AY; Kern SE
Mol Carcinog; 1999 Sep; 26(1):37-43. PubMed ID: 10487520
[TBL] [Abstract][Full Text] [Related]
9. The role of TGFbeta in human cancers.
Wong SF; Lai LC
Pathology; 2001 Feb; 33(1):85-92. PubMed ID: 11280615
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
11. Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.
Wimmel A; Wiedenmann B; Rosewicz S
Gut; 2003 Sep; 52(9):1308-16. PubMed ID: 12912863
[TBL] [Abstract][Full Text] [Related]
12. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta signaling in colon cancer cells.
Li F; Cao Y; Townsend CM; Ko TC
World J Surg; 2005 Mar; 29(3):306-11. PubMed ID: 15711891
[TBL] [Abstract][Full Text] [Related]
14. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
15. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
17. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
18. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
[TBL] [Abstract][Full Text] [Related]
19. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F; Pouponnot C; Massagué J
Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
[TBL] [Abstract][Full Text] [Related]
20. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.
Luo K; Stroschein SL; Wang W; Chen D; Martens E; Zhou S; Zhou Q
Genes Dev; 1999 Sep; 13(17):2196-206. PubMed ID: 10485843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
